Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
News
SCORED: Sotagliflozin shows robust MACE benefit
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 2, 2022
News

FDA okays semaglutide higher dose, 2 mg/week, for type 2 diabetes
- Author:
- Mitchel L. Zoler, PhD
Publish date: March 29, 2022
News

Empagliflozin scores topline win in EMPA-KIDNEY trial
- Author:
- Mitchel L. Zoler, PhD
Publish date: March 18, 2022
News
Finerenone + SGLT2 inhibitor of benefit in diabetes with CKD?
- Author:
- Mitchel L. Zoler, PhD
Publish date: March 4, 2022
News
Older age for menopause raises risk for lung cancer
- Author:
- Mitchel L. Zoler, PhD
Publish date: February 28, 2022
News
Uptake uncertain for potent new LDL-lowerer inclisiran
- Author:
- Mitchel L. Zoler, PhD
Publish date: January 26, 2022
News

Benign adrenal tumors linked to hypertension, type 2 diabetes
- Author:
- Mitchel L. Zoler, PhD
Publish date: January 6, 2022
News
More lots of metformin recalled
- Author:
- Mitchel L. Zoler, PhD
Publish date: January 3, 2022
News

New AKI risk score for PCI patients passes validation
- Author:
- Mitchel L. Zoler, PhD
Publish date: December 7, 2021
News

SGLT2 inhibitor use tied to fewer atrial arrhythmias
- Author:
- Mitchel L. Zoler, PhD
Publish date: December 2, 2021
News
Type 2 diabetes remission can happen naturally in 1 in 20
- Author:
- Mitchel L. Zoler, PhD
Publish date: November 22, 2021
News
Advanced CKD doesn’t derail empagliflozin in EMPEROR-preserved
- Author:
- Mitchel L. Zoler, PhD
Publish date: November 19, 2021
News

EMPEROR-Preserved findings confirmed in ‘true’ HFpEF patients
- Author:
- Mitchel L. Zoler, PhD
Publish date: November 17, 2021
News
Oral daprodustat safely improves anemia in chronic kidney disease
- Author:
- Mitchel L. Zoler, PhD
Publish date: November 16, 2021
News

ASCEND: Aspirin shows hint of dementia protection in T2D
- Author:
- Mitchel L. Zoler, PhD
Publish date: November 16, 2021